532 related articles for article (PubMed ID: 3081262)
1. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
2. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subset alterations in nodes regional to human melanoma.
Farzad Z; Cochran AJ; McBride WH; Gray JD; Wong V; Morton DL
Cancer Res; 1990 Jun; 50(12):3585-8. PubMed ID: 1692763
[TBL] [Abstract][Full Text] [Related]
5. [Modified radical mastectomy and lymphocyte subsets of regional lymph nodes].
Nakajima Y; Akimoto M; Kimura M; Sawano A; Iwasaki H; Abe R; Kasai M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2182-6. PubMed ID: 3717962
[TBL] [Abstract][Full Text] [Related]
6. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
Abo T; Miller CA; Balch CM
Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
9. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
Hendler FJ; House D
Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
[TBL] [Abstract][Full Text] [Related]
10. [Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432].
Nakajima Y; Akimoto M; Kimura M; Matano S; Hirakawa H; Kasai M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2766-71. PubMed ID: 2428312
[TBL] [Abstract][Full Text] [Related]
11. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of axillary lymph node cells in patients with breast cancer.
Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
[TBL] [Abstract][Full Text] [Related]
13. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens.
Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F
J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102
[TBL] [Abstract][Full Text] [Related]
16. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
17. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
Atkinson K
Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
[TBL] [Abstract][Full Text] [Related]
18. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
19. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues.
Hsu SM; Jaffe ES
Am J Pathol; 1984 Mar; 114(3):387-95. PubMed ID: 6421166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
